Mitsubishi Gas Chemical, Nisshin Pharma to Jointly Organize CoQ10 Business.Tokyo, Japan, Apr 21, 2006 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) ) - Mitsubishi Gas Chemical (MGC MGC Mammalian Gene Collection MGC Media Gateway Controller MGC Middle Georgia College MGC Museums and Galleries Commission (UK government) MGC Mississippi Gaming Commission MGC Manual Gain Control ) will launch a joint venture with Nisshin Pharma, a Nisshin Seifun Group company, concerning coenzyme Q coenzyme Q n. Ubiquinone. 10 (CoQ CoQ coenzyme Q (ubiquinone). 10). Nisshin Pharma has acquired a 10% stake in Japan Bio, a wholly owned CoQ10 business subsidiary of MGC. Japan Bio has been constructing a production facility with an annual output capacity of 40 tons at its Niigata Plant since last year. MGC will supply CoQ10 to Nisshin Pharma based on the capital ratio. With this move, the two companies aim to ensure the stable supply of CoQ10 in the Japanese market. Copyright [c] 2006 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion